,,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu', 'destiny-breast04', '$azn', '$dsnky']
an impressive chart from the nejm destiny-breast04 publication. enhertu responses across both measures of her2 expression (low and very low!) and er-neg disease. $azn $dsnky #asco22 
Pharma and biotech reporter, found a home at Evaluate Vantage.